Edward Helmes1, Jhan Landmark. 1. School of Psychology, James Cook University, Townsville Qld 4811, Australia. edward.helmes@jcu.edu.au
Abstract
OBJECTIVES: To identify empirical subtypes of schizophrenia, based upon the symptoms recorded over the duration of the illness, and to validate the resulting clusters against other systems that are used for subtyping schizophrenia. METHOD: Data for 55 symptoms of schizophrenia over the history of the illness from 107 chronic schizophrenia patients were analyzed using hierarchical cluster analysis with Euclidean distance and Ward's method. Except for 1 patient, all met DSM-III criteria. There were 40 men and 67 women, average (SD) age of 38.2 (9.91) years, with a mean (SD) hospitalization of 27.9 (27.35) months. RESULTS: No clear and unambiguous solution for the number of clusters was evident. Examination of the clusters led to further analysis of 2- and 6-cluster solutions. These were contrasted with DSM-III, DSM-III-R, and DSM-IV criteria and with the subtypes taken from the literature. There was limited support for any of these types, with none replicating, including the paranoid-nonparanoid distinction. CONCLUSIONS: Empirical clusters derived from lifetime symptom data failed to agree with either the established DSM or other empirically derived subtypes. Subtypes may have little utility when the variability of symptoms over the longitudinal course of the illness is considered.
OBJECTIVES: To identify empirical subtypes of schizophrenia, based upon the symptoms recorded over the duration of the illness, and to validate the resulting clusters against other systems that are used for subtyping schizophrenia. METHOD: Data for 55 symptoms of schizophrenia over the history of the illness from 107 chronic schizophreniapatients were analyzed using hierarchical cluster analysis with Euclidean distance and Ward's method. Except for 1 patient, all met DSM-III criteria. There were 40 men and 67 women, average (SD) age of 38.2 (9.91) years, with a mean (SD) hospitalization of 27.9 (27.35) months. RESULTS: No clear and unambiguous solution for the number of clusters was evident. Examination of the clusters led to further analysis of 2- and 6-cluster solutions. These were contrasted with DSM-III, DSM-III-R, and DSM-IV criteria and with the subtypes taken from the literature. There was limited support for any of these types, with none replicating, including the paranoid-nonparanoid distinction. CONCLUSIONS: Empirical clusters derived from lifetime symptom data failed to agree with either the established DSM or other empirically derived subtypes. Subtypes may have little utility when the variability of symptoms over the longitudinal course of the illness is considered.
Authors: Ji Chen; Kaustubh R Patil; Susanne Weis; Kang Sim; Thomas Nickl-Jockschat; Juan Zhou; André Aleman; Iris E Sommer; Edith J Liemburg; Felix Hoffstaedter; Ute Habel; Birgit Derntl; Xiaojin Liu; Jona M Fischer; Lydia Kogler; Christina Regenbogen; Vaibhav A Diwadkar; Jeffrey A Stanley; Valentin Riedl; Renaud Jardri; Oliver Gruber; Aristeidis Sotiras; Christos Davatzikos; Simon B Eickhoff Journal: Biol Psychiatry Date: 2019-09-23 Impact factor: 12.810
Authors: Rosa Lundbye Allesøe; Ron Nudel; Wesley K Thompson; Yunpeng Wang; Merete Nordentoft; Anders D Børglum; David M Hougaard; Thomas Werge; Simon Rasmussen; Michael Eriksen Benros Journal: Sci Adv Date: 2022-06-29 Impact factor: 14.957
Authors: Cota Navin Gupta; Eduardo Castro; Srinivas Rachkonda; Theo G M van Erp; Steven Potkin; Judith M Ford; Daniel Mathalon; Hyo Jong Lee; Bryon A Mueller; Douglas N Greve; Ole A Andreassen; Ingrid Agartz; Andrew R Mayer; Julia Stephen; Rex E Jung; Juan Bustillo; Vince D Calhoun; Jessica A Turner Journal: Front Psychiatry Date: 2017-09-26 Impact factor: 4.157
Authors: Helena Pelin; Marcus Ising; Frederike Stein; Susanne Meinert; Tina Meller; Katharina Brosch; Nils R Winter; Axel Krug; Ramona Leenings; Hannah Lemke; Igor Nenadić; Stefanie Heilmann-Heimbach; Andreas J Forstner; Markus M Nöthen; Nils Opel; Jonathan Repple; Julia Pfarr; Kai Ringwald; Simon Schmitt; Katharina Thiel; Lena Waltemate; Alexandra Winter; Fabian Streit; Stephanie Witt; Marcella Rietschel; Udo Dannlowski; Tilo Kircher; Tim Hahn; Bertram Müller-Myhsok; Till F M Andlauer Journal: Neuropsychopharmacology Date: 2021-06-14 Impact factor: 7.853